Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of ASP015K - Evaluation of Pharmacokinetics in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function

NCT02586194 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02586194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of ASP015K - Evaluation of Pharmacokinetics in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
December 28, 2015
Completion date
September 27, 2016
Enrollment
24 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

patients with impaired hepatic function